Apyx Medical is moving into full commercial mode for its new AYON body contouring system and will host a...

Novartis has launched a cash tender offer to acquire all outstanding shares of Tourmaline Bio at $48 per share,...

FDA has advised IO Biotech not to submit a biologics license application for Cylembio in first-line advanced melanoma after...

Inventiva reported first-half 2025 results and a materially extended cash runway on the back of a €115.6 million second...

Clinuvel is advancing sustained-release liquid formulations for peptides into preclinical development, targeting multiple release profiles with an initial focus...

Profusa deepens its European presence through a strategic collaboration with Prof. Dr. Marianne Brodmann at the Medical University of...

Kraig Biocraft Laboratories’ opening of its second Southeast Asian silk production facility marks a significant step towards commercial-scale production...

Minovia Therapeutics Secures Funding, Reinforcing the Rise of Mitochondrial Medicine Minovia Therapeutics, a clinical-stage biotech company focused on mitochondrial...

Quell Therapeutics has established a Scientific Advisory Board to steer its engineered T‑regulatory cell therapy portfolio, spanning transplantation and...

Idorsia has released an on-demand investor briefing positioning Tryvio (aprocitentan) as a foundational add-on for difficult-to-control hypertension, with a...